YaoGeJu

Company directoryChina company filings

Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

As of 17 November 2026, for the company name Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. as recorded, 11 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 39 records, across 22 drug names; since 21 August 2026, the records list Accepted: 3 applications, No longer listed under review: 3 applications; the chemical-drug catalogue lists 20 active records with this name as holder; 23 active API registrations list this name as first registered company; 11 further acceptance records name it after the first applicant.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/17
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/17.

Drug filings

39 acceptance records as first applicant, grouped into 22 source drug names. Source data as of 2026/11/17.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Dydrogesterone Tablets 1 records · Latest accepted 2026/10/19

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602566Generic2026/10/19Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
雌二醇地屈孕酮片 · No verified English name 1 records · Latest accepted 2026/10/13

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602510Generic2026/10/13Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
Thymalfasin for Injection 1 records · Latest accepted 2026/09/10

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2601718Supplement2026/09/10Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name 14 records · Latest accepted 2026/04/22

New drug · 14

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHS2600057New drug2026/04/22Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
CXHS2600056New drug2026/04/22Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
CXHS2600055New drug2026/04/22Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
CXHS2600054New drug2026/04/22Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
CXHS2600053New drug2026/04/09Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
CXHS2600052New drug2026/04/09Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
CXHS2600051New drug2026/04/09Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
CXHS2600050New drug2026/04/09Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
CXHL2400713New drug2024/07/16Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
CXHL2400712New drug2024/07/16Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
CXHL2400686New drug2024/07/10Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
CXHL2400685New drug2024/07/10Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
CXHL2400684New drug2024/07/10Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
CXHL2400683New drug2024/07/10Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
Clindamycin Palmitate Hydrochloride Granules 1 records · Latest accepted 2025/05/15

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501776Generic2025/05/15Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
Roxadustat Capsules 2 records · Latest accepted 2025/04/23

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501521Generic2025/04/23Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
CYHS2501520Generic2025/04/23Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
Glucosamine Sulfate Capsules 1 records · Latest accepted 2025/03/25

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501169Generic2025/03/25Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
Vonoprazan Fumarate Tablets 2 records · Latest accepted 2025/02/07

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500585Generic2025/02/07Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
CYHS2500584Generic2025/02/07Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
Amlodipine Besylate and Atorvastatin Calcium Tablets 1 records · Latest accepted 2025/01/27

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2500227Supplement2025/01/27Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
依折麦布阿托伐他汀钙片(I) · No verified English name 1 records · Latest accepted 2024/11/30

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2402030Supplement2024/11/30Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.; Jiangxi Shimei Pharmaceutical Co., LtdCDE ↗
Ezetimibe and Atorvastatin Calcium Tablets(II) 1 records · Latest accepted 2024/11/30

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2402031Supplement2024/11/30Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.; Jiangxi Shimei Pharmaceutical Co., LtdCDE ↗
Atorvastatin Calcium Tablets 2 records · Latest accepted 2024/09/14

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2401493Supplement2024/09/14Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.; Shandong Lukang Group Saite Co., Ltd.CDE ↗
CYHB2401492Supplement2024/09/14Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.; Shandong Lukang Group Saite Co., Ltd.CDE ↗
Epalrestat Tablets 1 records · Latest accepted 2024/07/03

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2401994Generic2024/07/03Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
Agomelatine Tablets 1 records · Latest accepted 2024/07/03

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2401993Generic2024/07/03Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
Atosiban Acetate Injection 2 records · Latest accepted 2024/04/03

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2401001Generic2024/04/03Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
CYHS2401000Generic2024/04/03Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
磷酸奥司他韦干糖浆 · No verified English name 1 records · Latest accepted 2024/02/29

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2400314Supplement2024/02/29Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.; Jiangxi Shimei Pharmaceutical Co., LtdCDE ↗
Fluvoxamine Maleate Tablets 1 records · Latest accepted 2024/02/08

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2400595Generic2024/02/08Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
Cetrorelix Acetate for Injection 1 records · Latest accepted 2024/02/02

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2400431Generic2024/02/02Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
Oseltamivir Phosphate For Oral Suspension 1 records · Latest accepted 2023/02/15

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2300525Generic2023/02/15Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.; Tianjin Han Rui Pharma Co., Ltd. romanizedCDE ↗
复方匹可硫酸钠颗粒 · No verified English name 1 records · Latest accepted 2023/02/02

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2300307Generic2023/02/02Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
Olmesartan Medoxomil and Amlodipine Besylate Tablets 1 records · Latest accepted 2022/02/21

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200352Generic2022/02/21Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
Bivalirudin for Injection 1 records · Latest accepted 2021/09/03

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2101681Generic2021/09/03Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗

Changes in the last 90 days

6 events from 2026/08/21 to 2026/11/18. CDE data as of 2026/11/17; NMPA data as of 2026/11/17.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Accepted: 3 applicationsNo longer listed under review: 3 applications

  1. 2026/11/14No longer listed under review

    Roxadustat Capsules

    CYHS2501521

    Fact date: 2026/11/14 · Date added to this site: 2026/11/14

    Accepted: 2025/04/23

    no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked

    View source ↗
  2. 2026/11/14No longer listed under review

    Roxadustat Capsules

    CYHS2501520

    Fact date: 2026/11/14 · Date added to this site: 2026/11/14

    Accepted: 2025/04/23

    no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked

    View source ↗
  3. 2026/11/13No longer listed under review

    Dydrogesterone Tablets

    CYHS2602566

    Fact date: 2026/11/13 · Date added to this site: 2026/11/13

    Accepted: 2026/10/19

    no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked

    View source ↗
  4. 2026/10/19Accepted

    Dydrogesterone Tablets

    CYHS2602566

    Fact date: 2026/10/19 · Date added to this site: 2026/10/21

    View source ↗
  5. 2026/10/13Accepted

    雌二醇地屈孕酮片 · No verified English name

    CYHS2602510

    Fact date: 2026/10/13 · Date added to this site: 2026/10/21

    View source ↗
  6. 2026/09/10Accepted

    Thymalfasin for Injection

    CYHB2601718

    Fact date: 2026/09/10 · Date added to this site: 2026/10/21

    View source ↗

Under review

11 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/17.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
雌二醇地屈孕酮片 · No verified English name CYHS2602510Generic2026/10/13Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
Thymalfasin for Injection CYHB2601718Supplement2026/09/10Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name CXHS2600057New drug2026/04/22Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name CXHS2600056New drug2026/04/22Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name CXHS2600055New drug2026/04/22Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name CXHS2600054New drug2026/04/22Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name CXHS2600053New drug2026/04/09Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name CXHS2600052New drug2026/04/09Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name CXHS2600051New drug2026/04/09Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name CXHS2600050New drug2026/04/09Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
Clindamycin Palmitate Hydrochloride Granules CYHS2501776Generic2025/05/15Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗

Catalogue holder records

20 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/17. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Vonoprazan Fumarate TabletsJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.国药准字H202655322026/08/04Generic approved under the new chemical-drug registration classificationCDE ↗
Vonoprazan Fumarate TabletsJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.国药准字H202655332026/08/04Generic approved under the new chemical-drug registration classificationCDE ↗
Epalrestat TabletsJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.国药准字H202633992026/02/10Generic approved under the new chemical-drug registration classificationCDE ↗
Atosiban Acetate InjectionJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.国药准字H202561432025/12/03Generic approved under the new chemical-drug registration classificationCDE ↗
Atosiban Acetate InjectionJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.国药准字H202561442025/12/03Generic approved under the new chemical-drug registration classificationCDE ↗
Agomelatine TabletsJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.国药准字H202550262025/07/29Generic approved under the new chemical-drug registration classificationCDE ↗
Cetrorelix Acetate for InjectionJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.国药准字H202548952025/07/22Generic approved under the new chemical-drug registration classificationCDE ↗
Fluvoxamine Maleate TabletsJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.国药准字H202541752025/05/13Generic approved under the new chemical-drug registration classificationCDE ↗
Ezetimibe and Atorvastatin Calcium Tablets(II)Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Jiangxi Shimei Pharmaceutical Co., Ltd国药准字H202532672025/01/24Generic approved under the new chemical-drug registration classificationCDE ↗
依折麦布阿托伐他汀钙片(I) · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Jiangxi Shimei Pharmaceutical Co., Ltd国药准字H202532682025/01/24Generic approved under the new chemical-drug registration classificationCDE ↗
复方匹可硫酸钠颗粒 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.国药准字H202490162024/10/09Generic approved under the new chemical-drug registration classificationCDE ↗
Oseltamivir Phosphate For Oral SuspensionJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Tianjin Han Rui Pharma Co., Ltd. romanized国药准字H202449192024/09/19Generic approved under the new chemical-drug registration classificationCDE ↗
磷酸奥司他韦颗粒 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Jiangxi Shimei Pharmaceutical Co., Ltd国药准字H202438262024/05/28Generic approved under the new chemical-drug registration classificationCDE ↗
Olmesartan Medoxomil and Amlodipine Besylate TabletsJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.国药准字H202339682023/07/25Generic approved under the new chemical-drug registration classificationCDE ↗
Bivalirudin for InjectionJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.国药准字H202336522023/06/07Generic approved under the new chemical-drug registration classificationCDE ↗
Oseltamivir Phosphate CapsulesJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.国药准字H202233492022/05/31Generic approved under the new chemical-drug registration classificationCDE ↗
Eptifibatide InjectionJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.国药准字H202135822021/07/20Generic approved under the new chemical-drug registration classificationCDE ↗
Thymalfasin for InjectionJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.国药准字H201933352021/01/18Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Alogliptin Benzoate TabletsJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.国药准字H202035022020/09/30Generic approved under the new chemical-drug registration classificationCDE ↗
Glucosamine Sulfate CapsulesJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.国药准字H202656492026/08/18Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

23 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/17.

NameCompany / applicantRegistration numberStatusSource update dateView source
司美格鲁肽 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20250001233I2026/03/16CDE ↗
依折麦布 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20260000100I2026/02/11CDE ↗
玛仕度肽 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20250001166I2025/11/05CDE ↗
艾普拉唑 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20250000996I2025/09/19CDE ↗
罗沙司他 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20250000239A2026/10/14CDE ↗
联苯苄唑 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20240000565A2026/06/02CDE ↗
醋酸阿托西班 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20240000039A2025/11/21CDE ↗
舒林酸 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20230001372A2026/07/09CDE ↗
醋酸去氨加压素 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20220001250A2025/07/25CDE ↗
利拉鲁肽 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20220000633I2023/02/07CDE ↗
司美格鲁肽 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20220001086I2023/01/10CDE ↗
依帕司他 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20220001175A2026/07/18CDE ↗
匹可硫酸钠 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20220000698A2024/10/17CDE ↗
醋酸西曲瑞克 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20220000567A2024/06/06CDE ↗
阿托伐他汀钙 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20210001031A2025/08/10CDE ↗
氟维司群 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20200001489A2025/08/24CDE ↗
艾博韦泰 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20200001298A2023/07/12CDE ↗
磷酸奥司他韦 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20200000736A2026/10/11CDE ↗
醋酸奥曲肽 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20180001746A2025/08/23CDE ↗
比伐芦定 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20190000290A2025/08/23CDE ↗
依替巴肽 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20180001360A2026/04/13CDE ↗
苯甲酸阿格列汀 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20180000506A2025/02/19CDE ↗
胸腺法新 · No verified English nameJiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.Y20170001373A2023/07/14CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

11 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/17.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Estradiol Valerate Tablets CYHS2601955Generic2026/08/10Shandong Qidu Pharmaceutical Co., Ltd.; Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
玛仕度肽注射液 · No verified English name CYHB2601113Supplement2026/06/12Xin Da Biopharmaceutical (Suzhou) Co., Ltd. romanized; Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
玛仕度肽注射液 · No verified English name CYHB2502608Supplement2025/12/30Xin Da Biopharmaceutical (Suzhou) Co., Ltd. romanized; Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name JTS2400160Not stated by source2024/12/10Novo Nordisk A/S; Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name JTS2400129Not stated by source2024/10/18Novo Nordisk A/S; Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name JTS2400128Not stated by source2024/10/18Novo Nordisk A/S; Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name JTS2400127Not stated by source2024/10/18Novo Nordisk A/S; Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name JTS2400126Not stated by source2024/10/18Novo Nordisk A/S; Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name JTS2400125Not stated by source2024/10/18Novo Nordisk A/S; Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
Alogliptin Benzoate Tablets CYHB2300007Supplement2023/01/04Zhejiang Hua Bei Pharma Co., Ltd. romanized; Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗
Amlodipine Besylate and Atorvastatin Calcium Tablets CYHS2200454Generic2022/03/16Zhejiang Zhang Dian Drug Technology Kai Fa Co., Ltd. romanized; Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/17
Chemical-drug catalogue
Last successful update: 2026/11/17
API registrations
Last successful update: 2026/11/17
NMPA drug delivery notices
Last successful update: 2026/11/17

Loaded notices dated 2026-11-03 to 2026-11-17; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.